Pittenger & Anderson Inc Guardant Health, Inc. Transaction History

Pittenger & Anderson Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 14, 2022	SELL	$28.82 - $77.35 $1,585 - $4,254	-55 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$48.25 - $100.49 $5,838 - $12,159	-121 Reduced 68.75%	55 $4,000
Q4 2021 Feb 10, 2022	SELL	$88.71 - $120.43 $1,241 - $1,686	-14 Reduced 7.37%	176 $18,000
Q3 2021 Nov 12, 2021	BUY	$98.77 - $132.17 $987 - $1,321	10 Added 5.56%	190 $24,000
Q2 2021 Aug 13, 2021	BUY	$109.77 - $165.68 $5,927 - $8,946	54 Added 42.86%	180 $22,000
Q4 2020 Feb 11, 2021	BUY	$99.96 - $135.93 $8,496 - $11,554	85 Added 207.32%	126 $16,000
Q4 2019 Feb 12, 2020	BUY	$59.49 - $82.78 $654 - $910	11 Added 36.67%	41 $3,000
Q1 2019 May 10, 2019	BUY	$34.3 - $97.98 $1,029 - $2,939	30 New	30 $2,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

Stay updated on Pittenger & Anderson Inc with notifications on news.